IndraLab

Statements


| 4

reach
"Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy."

reach
"In addition, the new biphenyl diester derivative AB-38b has been demonstrated to attenuate diabetic nephropathy by suppressing NLRP3 via Nrf2 activation (20)."

reach
"Correction to: Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy."

reach
"Correction to : novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy."